Victoria Gray spent 34 years battling the debilitating pain of sickle cell disease. Then she volunteered to be the world's first "prototype" for a CRISPR therapy, based on technology invented at UC ...

Detailed price information for Microbix Biosystems Inc (MBXBF) from The Globe and Mail including charting and trades.

A natural, superabsorbent material developed at the University of Waterloo could dramatically reduce the environmental impact ...

Scientists are turning a stubborn waste problem from the beer industry into a surprisingly effective tool for making ...

For the first time, researchers at the University of British Columbia have demonstrated how to reliably produce an important type of human immune cell—known as helper T cells—from stem cells in a ...

In much of Africa, limited and unreliable grid coverage means many depend on polluting diesel generators to power their homes and businesses. South African start-up Hyena has a new hydrogen technology ...

While metabolomics is the large-scale comprehensive profiling of metabolites and other small molecules in the context of ...

About Fate Therapeutics, Inc. Fate Therapeutics is a clinical-stage biopharmaceutical company dedicated to bringing a pipeline of induced pluripotent stem cell (iPSC)-derived cellular immunotherapies ...

Randomness inside cells can decide whether a cancer returns after chemotherapy or whether an infection survives antibiotics.

New math model controls biological noise at single-cell level, offering a path to tackle cancer relapse and drug resistance.

Why does cancer sometimes recur even after successful treatment, or why do some bacteria survive despite the use of powerful ...

It has been claimed that because most of our DNA is active, it must be important, but now human-plant hybrid cells have been ...